INTRODUCTION
Cardiovascular heart disease and also the occurrence ofgallstones are believed to be associated with a Western lifestyle and to be aggravated by an inappropriate diet (Grundy et al., 1985; Pixley and Mann, 1988; Grundy, 1990) . Cooking, farming and factory food processing have all contributed to making food more rapidly digestible, to reducing the bulk of food that has to be eaten for survival and, consequently, to reducing the quantity of digested and partially digested food that enters the large intestine . For example, the amount of undigested starch that reaches the large intestine is affected by its source and preparation. Starch from uncooked potatoes and bananas is almost completely undigestible (Walker and Hope, 1963; Englyst and Cummings, 1986) and, as cooked starch cools, its digestibility decreases . The fine milling of cereals, especially as opposed to stone grinding, produces a flour that is more rapidly and completely digested (O'Dea et al., 1980; Snow and O'Dea, 1981; Heaton et al., 1988; O'Donnell et al., 1989) . Here, using trestatin to inhibit starch degradation (Yokose et al., 1983a; Eichler et al., 1984) , we show that bile-salt metabolism, which may have a role in both cardiovascular heart disease and gallstone formation, is influenced by starch that escapes degradation in the small intestine. (Yokose et al., 1983b) . Other reagents were of analytical quality or were the purest available.
MATERIALS AND METHODS
Assay conditions for the determination of binding constants The buffer used to prepare the incubation solutions contained 150 mM NaCl and 2 mM Bes, adjusted with NaOH to pH 7.2. Incubations were carried out overnight at room temperature (-22°C) with vigorous shaking. The insoluble chelator was precipitated by centrifugation, and the radioactivity in the supernatant was measured.
Insoluble complexes For these, two procedures were followed: in the first, a fixed concentration (50 or 100,uM) of radiolabelled bile salt was incubated with different amounts of the insoluble polymer (1-16 mg cholestyramine and 10-160 mg of starch in 5 ml of the buffer); in the second, a fixed concentration of both the insoluble polymer (1.6 mg/ml) and [14C]chenodeoxycholate (-1 nM) were incubated with different concentrations of unlabelled chenodeoxycholate (the maximum concentration used did not exceed the critical micellar concentration).
Soluble complexes
For these, the first procedure described for insoluble complexes was followed, the bile salt being incubated with different amounts of cholestyramine in both the absence and presence of a fixed concentration (1 mM) of the soluble chelator. Solving eqn.
(1) for BI gives a quadratic, of which the negative root, used in curve-fitting, is: 
Eqn. (6) was used to determine the dissociation constant (KDs) of a soluble chelator-bile-salt complex. To do this, a fixed concentration of the soluble chelator (S) plus a fixed concentration of the bile salt (B1) were incubated with different amounts (I) of an insoluble chelator with a known dissociation constant (KDI) for the bile salt (see, e.g. Figure 3c below).
Analysis of binding data
At the end of the incubations, the radioactivity in the supernatant was measured and expressed as a fraction of the total radioactivity. These binding data were then analysed by a non-linear least-squares curve-fitting procedure. For insoluble polymers, the parameter KDI in eqn. (3) (Eichler et al., 1984) , to the diet increases the weight of the faeces (see Figure 1) (Figure 2a) . However, in contrast with trestatin, it does not increase the weight of the faeces (Table 1) . a-Cyclodextrin (cyclohexaamylose) acts like cellulose: it increases the bulk of the faeces, but has no effect on the elimination of bile salts. y-Cyclodextrin (cycloocta-amylose), like starch from maize and cassava, has no effect.
Unlike trestatin and ,3-cyclodextrin, cholestyramine, an anionexchange resin that is used in man as a bile-salt chelator, increases the loss of radioactivity in the faeces of mice from both the intravenously injected [u4C] cholate are similar to those described above in the mouse (Table  2) .
Binding of bile salts to starch, cyclodextrins and cholestyramine in vitro
In vitro, potato, maize and cassava starch all bind the taurine conjugate of chenodeoxycholate, deoxycholate and cholate. The stability of the bile-salt-starch complex derived from incubations of a fixed concentration of bile salt with different concentrations of starch is, within the accuracy of the determinations, independent of the source of the starch, but highly dependent on the bile salt ( Figure 3a and accuracy of the determinations, the stability of the complex between potato starch and bile salts is independent of whether the bile salt is unconjugated or conjugated with either glycine or taurine (Table 3 ). The dissociation constant ofthe bile-salt-starch complex decreases from cholate (370 mg/ml) to deoxycholate (39 mg/ml) to chenodeoxycholate (4 mg/ml; averages from data in Table 3 ). The accuracy ofthe dissociation constants determined for the cholate complexes is very low, because, at the highest starch concentration used, only about 10 % of the bile salt is bound ( Figure 3a) . As expected from the data in Figure 3a , dissociation constants derived from incubations of a fixed concentration of potato and cassava starch with different concentrations of taurochenodeoxycholate are similar: 128 ,#M with potato and 152 ,uM with cassava starch (see Figure 3 and Table  4 ). (11) The KD of the complex between the insoluble polymers and the bile salts was determined by incubating a fixed concentration of the bile salt with different concentrations of the polymer (see, e.g., Figure 3a ). The KD, therefore, has the same units of concentration as the polymer. The KD values for a-, /1-and y-cyclodextrins are also given as a weight concentration (Mr 972, 1135 and 1297 respectively) . The values are given as KD±S.E.M. (or S.E.) (n) where n is the number of determinations; for n = 1 the S.E. of the fit is given, and for n > 1 the S.E.M. Each fit was made to six duplicate data points (in Figures 3a and 3c (1) 50±3 (1) 6+0 (1) 328 + 96 (2) 44 ± 8 (2) 4 +2 (2) 314+27 (1) 39±1 (1) 4 +0 ( 1) 239 + 22 (1) 30±1 (1) 3 + 0 (1) (12) 62 ± 5 (9) 56 + 6 (8) Figure 3b ). The parameters KDI and /(binding-site concentration) in eqn. (5) The affinity of ,-cyclodextrin for the various bile salts parallels that of starch, except that the discrimination between cholate and chenodeoxycholate is smaller (30-versus 100-fold); however, on a weight basis, the affinity of,i-cyclodextrin is at least 200-fold greater than that of starch (Table 3 ). The affinity ofy-cyclodextrin for taurine-conjugated bile salts is similar to that of J8-cyclodextrin, whereas the binding of bile salts to a-cyclodextrin could not be detected (Table 3) .
In contrast with starch and /-cyclodextrin, the affinity of the anion-exchange resin cholestyramine for chenodeoxycholate and deoxycholate is similar, and its affinity for chenodeoxycholate is less than 10-fold larger than for cholate. Also, in contrast with starch and fi-cyclodextrin the affinity of taurine-conjugated bile salts is higher than that of either unconjugated or glycineconjugated bile salts (Table 3) .
DISCUSSION
Trestatin inhibits the digestion of starch in the intestine (Eichler et al., 1984) , and, consequently, increases the weight of the faeces. The amount of radioactivity, from intravenously injected [14C] chenodeoxycholate, that appears in the faeces is linearly related to the increase in their weight, whereas that from [3H]cholate is not (Figure 1 ). This increased loss of radioactivity could be caused by trestatin itself, the increased weight of the faeces or the amount of starch in the faeces. A direct action of trestatin is unlikely as, in its absence, uncooked potato starch, which is resistant to degradation in the intestine (Walker and Hope, 1963) , also increases the loss of radioactivity. The increase in the weight of the faeces can be ruled out, because adding cellulose or a-cyclodextrin to the diet increases their weight without increasing the loss of radioactivity (Table 1 ). This leaves starch as the probable causative agent and therefore its interaction with bile salts was studied in vitro.
The stability of the bile-salt-starch complex in vitro is independent of the source of the starch (potato, maize or cassava; Figure 3a) , dependent on the bile salt (cholate, deoxycholate or chenodeoxycholate; Figure 3a ) and independent of whether the bile salt is unconjugated or conjugated with taurine or glycocholate (Table 3 ). The most likely binding site for an amphiphilic ligand in the starch molecule is in the hydrophobic interior of the helical structures that are formed by the 1,4-linked glucose units of amylose and amylopectin (Hinrichs et al., 1987 , and references therein). a-,-and y-cyclodextrin, which are produced by bacterial degradation of starch, are cyclic molecules that contain six, seven and eight glucose units respectively, and approximate to one turn of these helical structures (Saenger, 1980) . They have a hydrophobic central cavity, with a diameter of 0.47, 0.6 and 0.75 nm respectively, and form inclusion complexes with a large variety of hydrophobic and amphiphilic molecules (Saenger, 1980) . In contrast with ,-and y-cyclodextrin, a-cyclodextrin does not form complexes with taurine-conjugated bile salts (Table 3) , presumably because its central cavity is too small. The affinity of ,-and y-cyclodextrin, like that of starch, increases from taurocholate to taurodeoxycholate to taurochenodeoxycholate, but by a smaller factor (-1 to 10 to 100 for starch, 1 to 11 to 30 for ,-cyclodextrin, and 1 to 4 to 17 for y-cyclodextrin; Table 3 ).
On a weight basis the affinity of ,-and y-cyclodextrin for the taurine-conjugated bile salts is similar, whereas that of starch is at least 200 times weaker ( (Table 4) . These values are -10 times higher than that for /3-cyclodextrin (14 ,tg/ml or 12 ,M; Table  3 ). From the same incubations, the concentration of the binding sites in the incubation medium was found to be 33,uM for potato and 38 ,M for cassava starch and, as both starches were at 1.6 mg/ml, this gives one binding site per 320 and 265 glucose units respectively (Table 4) . These values are -40 times larger than that for ,-cyclodextrin. Assuming that the helical structures within starch are the binding sites for bile salts, then either their number is restricted to 1 per -300 glucose units or those in excess of this do not bind bile salts. The reason could be that they are physically inaccessible to bile salts or that, by analogy to acyclodextrin, their central cavity is too small.
The critical micellar concentrations (11,4 and 3 mM; Hofmann and Roda, 1984) and the relative retention times on reversedphase h.p.l.c. (1, 1.5 and 1.6; Ruben and van Berge-Henegouwen, 1982; 1, 1.8 and 1.9, Carducci et al., 1985) indicate that there is an increase in hydrophobicity from cholate to chenodeoxycholate to deoxycholate. In contrast, their affinity for starch and /,-cyclodextrin increases from cholate (3,7,12-trihydroxycholanic acid) to deoxycholate (3,12-dihydroxycholanic acid) to chenodeoxycholate (3,7-dihydroxycholanic acid; see Table 3 ). Evidently, the presence of the 7-hydroxy or, perhaps more probably, the absence of the 12-hydroxy group plays an important role in stabilizing the binding of bile salts to starch and cyclodextrins.
In both mice and hamsters, /8-cyclodextrin, like starch, increases the loss of radioactivity in the faeces from [14C]chenodeoxycholate, but not from [3H]cholate (Figures 1 and 2a and Tables 1 and 2 ). The much larger affinity of starch and /bcyclodextrin for chenodeoxycholate than for cholate (Table 3) apparently explains this difference. However, although this explanation may be relevant to the hamster, which has cholate, deoxycholate and chenodeoxycholate as its major bile salts, it is not directly relevant to the mouse, which converts chenodeoxycholate into a-muricholate (3,6,7-trihydroxycholanic acid). The affinity of this bile salt for starch and cyclodextrins is not known. In vivo, the situation is further complicated in that the bile salts that escape absorption in the small intestine are degraded by colonic bacteria, deoxycholate being the major degradation product of cholate and lithocholate of both z-muricholate and chenodeoxycholate.
There is an apparent discrepancy between the in vitro and in vivo data, in that, although /-and y-cyclodextrin have similar affinities for taurochenodeoxycholate (Table 3) (Tables 1 and 2 ). Further, they are both degraded in the intestine, as neither causes an increase in the weight of the faeces (Table 1) . However, their site of degradation differs: y-cyclodextrin is digested by the a-amylases in the small intestine, whereas ,-cyclodextrin is resistant (Mar-
